Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other financing activities (2018 - 2024)

Dianthus Therapeutics has reported Other financing activities over the past 3 years, most recently at $2.2 million for Q2 2024.

  • Quarterly results put Other financing activities at $2.2 million for Q2 2024, changed N/A from a year ago — trailing twelve months through Mar 2025 was $2.2 million (down 81.94% YoY), and the annual figure for FY2024 was $14.7 million, changed.
  • Other financing activities for Q2 2024 was $2.2 million at Dianthus Therapeutics, down from $12.4 million in the prior quarter.
  • Over the last five years, Other financing activities for DNTH hit a ceiling of $12.4 million in Q1 2024 and a floor of $2.2 million in Q2 2024.